Applications of advances in therapeutic electrical stimulation techniques and technologies in precision peripheral nerve repair: a narrative reviewKennedy, Vernon Jr.1,2 ; Long, Mackenzie D.1,3 ; Walters, Jordan1 ; Adewuyi, Adenike A.1,4 ; Franz, Colin K.1,4,5,6,* 1Regenerative Neurorehabilitation Laboratory, Shirley Ryan AbilityLab, Chicago, IL, USA 2The Northwestern University Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, IL, USA 3Department of Biomedical Engineering, Northwestern University, Evanston, IL, USA 4Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA 5Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA 6Kimberly K. Querrey and Louis A. Simpson Institute for Bioelectronics, Northwestern University, Evanston, IL, USA *Correspondence to: Colin K. Franz, MD, PhD, cfranz@sralab.org. Advanced Technology in Neuroscience 2(2):p 97-101, June 2025. | DOI: 10.4103/ATN.ATN-D-24-00023 Peripheral nerve injuries affect large numbers of individuals each year, often resulting in long-term disabilities due to impairments in motor and sensory function. With traditional treatment approaches, including surgical repair and rehabilitation, the most common outcome is incomplete recovery. This is compounded by the absence of FDA-approved medications to enhance nerve regeneration. Recent advances in therapeutic electrical stimulation techniques have shown promise to improve axonal regrowth and functional recovery. Typically administered perioperatively in a single 1-hour session, therapeutic electrical stimulation has demonstrated efficacy in both preclinical studies and small clinical trials by promoting faster and more complete axonal regeneration. To address the limitations of traditional therapeutic electrical stimulation, including infection risks or lead displacement, the recent development of bioresorbable nerve stimulator implants has introduced a groundbreaking solution. Furthermore, patient-specific factors, including age, sex, medical comorbidities, and genetic variability, notably interact with clinical outcomes and potential responsiveness to therapeutic electrical stimulation. Such genes include the prevalent Val66Met genetic polymorphism in the brain-derived neurotrophic factor gene (rs6265). Carriers of rs6265 have less nerve regeneration, impaired activity-dependent brain-derived neurotrophic factor secretion, and a diminished response to therapeutic electrical stimulation in preclinical studies. This highlights the growing importance of tailoring therapeutic electrical stimulation protocols to each patient for optimal outcomes. The future of therapeutic electrical stimulation in the treatment of peripheral nerve injury will involve the integration of more sophisticated nerve stimulators to deliver tailored therapeutic electrical stimulation protocols, with careful consideration given to patient-specific factors and personalized rehabilitation strategies to maximize functional recovery. 中文摘要 每年都有大量患者遭受周围神经损伤,通常会因运动和感觉功能受损而导致长期残疾。传统的治疗方法,包括手术修复和康复,最常见的结果是无法完全康复。此外,目前尚无FDA批准的增强神经再生药物,这加剧了这一问题。治疗性电刺激技术的最新进展已显示出改善轴突再生和功能恢复的潜力。治疗性电刺激通常在围手术期进行,每次持续1小时,已在临床前研究和小型临床试验中证实其能够促进更快、更彻底的轴突再生。为了解决传统治疗性电刺激的局限性(例如感染风险或导线移位),生物可吸收神经刺激器植入物的最新进展带来了突破性的解决方案。此外,患者自身因素(包括年龄、性别、合并症和遗传变异)与临床结果和对治疗性电刺激的潜在反应存在显著的相互作用。这些基因包括脑源性神经营养因子基因 (rs6265) 中普遍存在的 Val66Met 基因多态性。rs6265 基因携带者的神经再生能力较差,活动依赖性脑源性神经营养因子分泌受损,临床前研究表明,其对治疗性电刺激的反应较弱。这凸显了根据每位患者量身定制治疗性电刺激方案以获得最佳疗效的重要性。未来,治疗性电刺激在周围神经损伤治疗中的应用将涉及整合更先进的神经刺激器,以提供定制的治疗性电刺激方案,并仔细考虑患者的具体因素和个性化康复策略,以最大程度地促进功能恢复。 |